- Paige raises $45M in Series B funding led by Healthcare Venture Partners with participation from Breyer Capital, Kenan Turnacioglu, and others. - The funding will be used to accelerate commercial efforts of its AI-native digital pathology ecosystem in the U.S., Europe, Brazil, and Canada. Paige, a NYC-based leader in computational pathology transforming the diagnosis and treatment of cancer, today announced it has closed its Series B funding round of $45 million, bringing the Company’s
Read More
Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant
Social Determinants of Health Trends in 2020: The End of the Beginning?
2020 will mark the end of the beginning of Social Determinants of Health (SDoH).
One would be remiss not to give pause and to consider how much time it has taken to get to this pivotal period in US health and healthcare delivery and, focus on the cornerstone “why” healthcare must, with a fierce urgency, step into the twenty-first century of US healthcare delivery. Meaning, it has taken nearly seventy years to go from the World Health Organization identifying the profundity of SDoH influence on
Read More
10 Factors Radiologists Should Consider When Selecting AI Vendors
With over 150 independent software vendors developing machine learning solutions for medical imaging, sorting through the plethora of options to select vendors is a challenge. Here are 10 factors radiologists should consider (and questions they should ask) before partnering with vendors providing AI solutions for medical imaging.
1. Clinical Relevancy
The foremost consideration for healthcare providers adopting AI into their clinical workflow is relevancy. Does the AI solution truly
Read More
Life Image, Graticule Launches Imaging Dataset In AWS Data Exchange
- Life Image and Graticule announced the availability of GLIMPS (Graticule Life Image Machine Parsed Set) data licensing subscriptions in AWS Data Exchange. - GLIMPS (Graticule Life Image Machine Parsed Set) is a de-identified patient-level data set including a summary of features generated from NLP processing on Life Image data. - The goal of GLIMPS is to provide a cost-effective patient-level snapshot to biopharma data science teams to fuel the necessary discussions about these data, leading
Read More
Philips, Dept. of Defense Partner to Develop AI-Algorithm to Detect Infection 48 Hours Before Observable Symptoms
- Philips and the U.S. Department of Defense are teaming up to develop an AI-algorithm to identify infection more than 48 hours before observable symptoms.
- Using large data sets & machine learning across biomarkers, innovative tech can speed time to detection, intervention & treatment, while improving outcomes & reducing the spread of disease.
- Future research is currently being planned to leverage this information as an algorithm to be integrated into a wearable device,
Read More
Backed by Optum Ventures, Kaia Health Raises $8M for AI-Driven Digital Therapeutics for Back Pain & COPD
- Digital therapeutics startup Kaia Health raises $8M in funding led by Optum Ventures to support the accelerated execution of clinical trials required to demonstrate efficacy to the FDA.- Kaia Health utilizes multimodal therapy, which combines physical, psychological and educational elements to relieve back pain at home, without medication.- Optum’s investment in Kaia Health will consider use of Kaia Health’s digital therapeutic offerings for back pain and COPD with Optum and UnitedHealth
Read More
Geisinger, IBM Develops Predictive Model Using EHR Data to Detect Sepsis
- Geisinger/IBM’s AI and Data Science team are working together to prevent sepsis, life-threating infection through early detection and research.
- Geisinger team used IBM Watson Studio open-source tools to build a predictive model that would ingest clinical data from thousands of de-identified sepsis patients spanning a decade.
- Geisinger uses IBM Watson Explorer to create a searchable index of thousands of medical publications for clinicians and researchers can now mine the journal
Read More
Quest Diagnostics to Contribute Biomarker Datasets to Support One Brave Idea Initiative
In a move to advance the ground-breaking work to identify coronary heart disease at the earliest transition from wellness to disease, Quest Diagnostics announced it will contribute biomarker implementation, population health analytics and a national lab platform as a pillar supporter of One Brave Idea, the research initiative co-founded by the American Heart Association (AHA) and Verily Life Sciences with significant support from AstraZeneca.The Burden of Cardiovascular DiseaseHeart disease is
Read More
Yale, Mayo Clinic, Biofourmis Launches Research to Detect Heart Failure Using Wearable Biosensor Data
Biofourmis has entered a research partnership with the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI). Biofourmis' mobile platform BiovitalsHFTM will be leveraged in a study of patients with heart failure to monitor functional capacity and quality of life to see if greater emphasis should be placed on these measures in the drug approval process.Impact of Heart FailureHeart failure afflicts approximately 6.5 million patients in the United States and
Read More
AMA Grants New CPT Code for KidneyIntelX to Support Medicare & Reimbursement
The American Medical Association (AMA) has granted a CPT® Proprietary Laboratory Analyses (PLA) Code for Renayltix AI’s lead product, KidneyIntelX. The new code, 0105U, has been approved and published by the AMA CPT Editorial Panel, and is scheduled to become effective on October 1, 2019.Medicare Price for New CPT CodeA payment rate for the new code will be established for Medicare patients through the 2019 Clinical Lab Fee Schedule (CLFS) Annual Public Meeting process. Renayltix AI will shortly
Read More
